DBPR116 is a brain-penetrant prodrug of BPRMU191. When co-administered with Naltrexone, it demonstrates potent analgesic efficacy in preclinical models, including thermal and cancer pain, while showing a reduced side-effect profile compared to morphine, making it a promising candidate for safer opioid analgesic research.
Molecular Weight:
359.42
CAS Number:
[2131200-75-2]
Formula:
C19H18FNO3S
Target:
Opioid Receptor
* VAT and and shipping costs not included. Errors and price changes excepted
